|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 47/34 | (2017.01) |
| A61K 31/519 | (2006.01) |
| (11) | Number of the document | 2529756 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12170362.3 |
| Date of filing the European patent application | 2012-05-31 | |
| (97) | Date of publication of the European application | 2012-12-05 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-19 |
| (46) | Date of publication of the claims translation | 2021-07-26 |
| (30) | Number | Date | Country code |
| PCT/EP2011/0590 | 2011-05-31 | WO | |
| PCT/EP2011/0590 | 2011-05-31 | WO |
| (72) |
Gutierro Aduriz, Ibon, ES
Franco Rodriguez, Guillermo, ES
|
| (73) |
LABORATORIOS FARMACEUTICOS ROVI, S.A.,
c/Julián Camarillo, 35, 28037 Madrid,
ES
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Risperidono ir (arba) paliperidono implantų kompozicija |
| Risperidone and/or Paliperidone implant formulation |
| Payment date | Validity (years) | Amount | |
| 2025-05-13 | 14 | 289.00 EUR |
| 2026-05-31 |